Policy and science at a crossroads: integrating new approach methodologies (NAMs) into anticancer drug testing

Guo Zhao1, Jiawei Zhou1, Shuhang Wang1

  • 1Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital of Chinese Academy of Medical Sciences Langfang Campus, Langfang 065001, China.

Science Bulletin
|June 6, 2026
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos